Sign in

Dimitre Genov

Managing Director at Private Investor

Dimitre Genov is a Managing Director at Brookline Capital Markets, specializing in advising clients on public, private, and alternative capital-raising strategies including SPACs, PIPEs, and public offerings. He has managed portfolios with peak assets under management in excess of $1 billion at Balyasny Asset Management and Magnetar Capital, with a notable focus on SPAC investments and global value strategies. His career spans three decades, beginning at Lazard in investment banking, and includes senior roles at JP Morgan, Julius Baer, Noster Capital, Magnetar Capital, and Balyasny, before joining Brookline Capital Markets in January 2024. Genov’s credentials are built on extensive experience in special situations investing, asset management, and financial analysis across major global financial institutions.

Dimitre Genov's questions to PROC leadership

Question · Q2 2023

Inquired about the basis for optimism for a strong Q4, the expected financial contribution from the Florida facilities, the current M&A strategy, and plans to increase the stock's liquidity.

Answer

The company's Q4 optimism is based on a strong portfolio of delayed CDMO orders, favorable currency exchange rates, and new product launches. They declined to provide specific financial projections for the Florida facilities. The M&A strategy is on hold for 2023 to focus on internal efficiencies and cash generation, with a potential return to M&A in 2024. To increase liquidity, they are using a share buyback program, engaging with smaller investment banks for broader coverage, and believe improving results will attract more investors.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts